272 related articles for article (PubMed ID: 25857234)
41. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations.
Yabuuchi H; Tamai I; Nezu J; Sakamoto K; Oku A; Shimane M; Sai Y; Tsuji A
J Pharmacol Exp Ther; 1999 May; 289(2):768-73. PubMed ID: 10215651
[TBL] [Abstract][Full Text] [Related]
42. Cytokine signaling in the human brain capillary endothelial cell line hCMEC/D3.
Fasler-Kan E; Suenderhauf C; Barteneva N; Poller B; Gygax D; Huwyler J
Brain Res; 2010 Oct; 1354():15-22. PubMed ID: 20692239
[TBL] [Abstract][Full Text] [Related]
43. A Proton-Coupled Transport System for β-Hydroxy-β-Methylbutyrate (HMB) in Blood-Brain Barrier Endothelial Cell Line hCMEC/D3.
Higuchi K; Sivaprakasam S; Sennoune SR; Ogura J; Bhutia YD; Rueda R; Pereira SL; Ganapathy V
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579098
[TBL] [Abstract][Full Text] [Related]
44. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
[TBL] [Abstract][Full Text] [Related]
45. Flavonoid metabolites transport across a human BBB model.
Faria A; Meireles M; Fernandes I; Santos-Buelga C; Gonzalez-Manzano S; Dueñas M; de Freitas V; Mateus N; Calhau C
Food Chem; 2014 Apr; 149():190-6. PubMed ID: 24295694
[TBL] [Abstract][Full Text] [Related]
46. The mystery of the human proton-organic cation antiporter: One transport protein or many?
Sachkova A; Jensen O; Dücker C; Ansari S; Brockmöller J
Pharmacol Ther; 2022 Nov; 239():108283. PubMed ID: 36162727
[TBL] [Abstract][Full Text] [Related]
47. Sodium Transporters Are Involved in Lithium Influx in Brain Endothelial Cells.
Luo H; Gauthier M; Tan X; Landry C; Poupon J; Dehouck MP; Gosselet F; Perrière N; Bellivier F; Cisternino S; Declèves X
Mol Pharm; 2018 Jul; 15(7):2528-2538. PubMed ID: 29874916
[TBL] [Abstract][Full Text] [Related]
48. Saturable distribution of tacrine into the striatal extracellular fluid of the rat: evidence of involvement of multiple organic cation transporters in the transport.
Sung JH; Yu KH; Park JS; Tsuruo T; Kim DD; Shim CK; Chung SJ
Drug Metab Dispos; 2005 Mar; 33(3):440-8. PubMed ID: 15547049
[TBL] [Abstract][Full Text] [Related]
49. A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC/D3 cells.
Qi D; Lin H; Hu B; Wei Y
J Control Release; 2023 Jun; 358():78-97. PubMed ID: 37076016
[TBL] [Abstract][Full Text] [Related]
50. Limitations of the hCMEC/D3 cell line as a model for Aβ clearance by the human blood-brain barrier.
Biemans EALM; Jäkel L; de Waal RMW; Kuiperij HB; Verbeek MM
J Neurosci Res; 2017 Jul; 95(7):1513-1522. PubMed ID: 27726164
[TBL] [Abstract][Full Text] [Related]
51. Organic cation rhodamines for screening organic cation transporters in early stages of drug development.
Ugwu MC; Oli A; Esimone CO; Agu RU
J Pharmacol Toxicol Methods; 2016; 82():9-19. PubMed ID: 27235784
[TBL] [Abstract][Full Text] [Related]
52. Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins.
Wu KC; Lu YH; Peng YH; Hsu LC; Lin CJ
J Neurochem; 2015 Dec; 135(6):1178-88. PubMed ID: 26376205
[TBL] [Abstract][Full Text] [Related]
53. Involvement of a Na
Higuchi K; Sato T; Bhutia YD; Ganapathy V
Pharm Res; 2020 May; 37(6):98. PubMed ID: 32419062
[TBL] [Abstract][Full Text] [Related]
54. L-Carnitine-conjugated nanoparticles to promote permeation across blood-brain barrier and to target glioma cells for drug delivery via the novel organic cation/carnitine transporter OCTN2.
Kou L; Hou Y; Yao Q; Guo W; Wang G; Wang M; Fu Q; He Z; Ganapathy V; Sun J
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1605-1616. PubMed ID: 28974108
[TBL] [Abstract][Full Text] [Related]
55. Parametric investigation of static and dynamic cell culture conditions and their impact on hCMEC/D3 barrier properties.
Hinkel S; Mattern K; Dietzel A; Reichl S; Müller-Goymann CC
Int J Pharm; 2019 Jul; 566():434-444. PubMed ID: 31163193
[TBL] [Abstract][Full Text] [Related]
56. Organic cation transporters in human nasal primary culture: expression and functional activity.
Shao D; Massoud E; Anand U; Parikh A; Cowley E; Clarke D; Agu RU
Ther Deliv; 2013 Apr; 4(4):439-51. PubMed ID: 23557285
[TBL] [Abstract][Full Text] [Related]
57. Studies of blood-brain barrier permeability of gastrodigenin in vitro and in vivo.
Mi Y; Mao Y; Cheng H; Ke G; Liu M; Fang C; Wang Q
Fitoterapia; 2020 Jan; 140():104447. PubMed ID: 31805306
[TBL] [Abstract][Full Text] [Related]
58. Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.
Suzuki T; Fukami T; Tomono K
Biopharm Drug Dispos; 2015 Mar; 36(2):126-37. PubMed ID: 25410756
[TBL] [Abstract][Full Text] [Related]
59. Carrier-Mediated Transport of Nicotine Across the Inner Blood-Retinal Barrier: Involvement of a Novel Organic Cation Transporter Driven by an Outward H(+) Gradient.
Tega Y; Kubo Y; Yuzurihara C; Akanuma S; Hosoya K
J Pharm Sci; 2015 Sep; 104(9):3069-75. PubMed ID: 25892000
[TBL] [Abstract][Full Text] [Related]
60. Substrates of the Human Brain Proton-Organic Cation Antiporter and Comparison with Organic Cation Transporter 1 Activities.
Doetsch DA; Ansari S; Jensen O; Gebauer L; Dücker C; Brockmöller J; Sachkova A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
